Factor | Total | ED visit | ORa | Standard error | P-Value | 95%CI |
---|---|---|---|---|---|---|
Age ≥ 65 years | 119 | 49 | 0.98 | 0.26 | 0.94 | 0.57, 1.66 |
Female gender | 112 | 37 | 0.54 | 0.15 | 0.03 | 0.32, 0.92 |
Married | 150 | 58 | 0.60 | 0.21 | 0.15 | 0.30, 1.19 |
Bachelor’s degree or above | 66 | 33 | 0.50 | 0.63 | 0.58 | 0.04, 5.78 |
Initial PPS level 50–90% | 122 | 60 | 2.02 | 0.56 | 0.01 | 1.18, 3.47 |
Comorbidities | ||||||
Hypertension | 71 | 26 | 0.56 | 0.16 | 0.06 | 0.35, 1.02 |
Diabetes mellitus | 61 | 28 | 0.67 | 0.22 | 0.21 | 0.36, 1.26 |
Dyslipidemia | 51 | 25 | 0.78 | 0.24 | 0.41 | 0.43, 1.41 |
Cardiovascular disease | 14 | 7 | 0.52 | 0.27 | 0.22 | 0.19, 1.46 |
Cerebrovascular disease | 16 | 9 | 0.69 | 0.38 | 0.50 | 0.23, 2.04 |
Dementia | 11 | 4 | 1.25 | 0.80 | 0.73 | 0.36, 4.40 |
ESRD | 5 | 4 | 0.17 | 0.19 | 0.12 | 0.02, 1.55 |
Primary site of neoplasm | ||||||
Colorectum | 42 | 17 | 0.84 | 0.32 | 0.65 | 0.40, 1.78 |
Liver and bile duct | 27 | 12 | 0.98 | 0.44 | 0.98 | 0.41, 2.36 |
Breast | 19 | 7 | 0.72 | 0.38 | 0.53 | 0.26, 2.01 |
Head and neck | 17 | 8 | 1.10 | 0.59 | 0.86 | 0.39, 3.12 |
Metastases | ||||||
Lung | 76 | 39 | 1.02 | 0.28 | 0.95 | 0.60, 1.74 |
Pleura | 25 | 16 | 1.23 | 0.46 | 0.57 | 0.60, 2.54 |
Bone | 65 | 24 | 0.84 | 0.25 | 0.57 | 0.47, 1.52 |
Lymph node | 112 | 48 | 1.21 | 0.33 | 0.48 | 0.71, 2.05 |
Liver | 86 | 38 | 1.20 | 0.33 | 0.51 | 0.70, 2.07 |
Peritoneum | 40 | 20 | 1.53 | 0.53 | 0.23 | 0.77, 3.03 |
Brain | 21 | 10 | 1.32 | 0.61 | 0.55 | 0.54, 3.25 |
Cancer treatments | ||||||
Chemotherapy | 138 | 59 | 0.80 | 0.22 | 0.43 | 0.47, 1.38 |
Surgery | 109 | 46 | 0.87 | 0.24 | 0.62 | 0.51, 1.48 |
Radiotherapy | 95 | 34 | 1.39 | 0.38 | 0.24 | 0.81, 2.38 |
Targeted therapy | 22 | 9 | 1.02 | 0.47 | 0.96 | 0.42, 2.50 |
Caregiver and family data | ||||||
Number of caregivers > 1 person | 41 | 19 | 1.34 | 0.47 | 0.41 | 0.67, 2.66 |
Family household members > 4 persons | 68 | 26 | 0.81 | 0.24 | 0.49 | 0.45, 1.46 |
Palliative care service data | ||||||
Number of palliative home visits > 1 time | 36 | 15 | 0.84 | 0.26 | 0.57 | 0.46, 1.54 |
Presence of advance directives | 35 | 5 | 1.29 | 0.74 | 0.66 | 0.42, 3.99 |
Time from initial palliative consultation to study endpoints | ||||||
16–100 days | 49 | 23 | 0.94 | 0.31 | 0.86 | 0.49, 1.81 |
> 100 days | 143 | 65 | 0.23 | 0.12 | 0.01 | 0.08, 0.66 |